Document is current
Any future updates will be listed below
-
Authors
Alibhai, A. Yasin
Moult, Eric M.
Jamil, Muhammad Usman
Raza, Khadija
Morales, Marco U.
Ribeiro, Ramiro
Baumal, Caroline R.
Fujimoto, James G.
Waheed, Nadia K.
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01EY011289)
- License Information
-
More Information
Article History
Received: 1 October 2024
Accepted: 21 December 2024
First Online: 7 January 2025
Declarations
:
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: A.Y.A is an employee at Boston Image Reading Center. M.U.M is an employee at Apellis. C.R.B. is an employee at Apellis. J.G.F. receives research support from Topcon Healthcare, has an equity interest in Optovue, and receives royalties on a patent owned by MIT and licensed to Optovue. N.K.W. receives research support from Carl Zeiss Meditec, Nidek, Regeneron and Topcon. She is Chief Medical Officer at Ocular therapeutics, has received speaker fees from Nidek, has an equity interest in AGTC, Iolyx pharmaceuticals, Valitor and Ocudyne, and is a consultant for Olix Therapeutics, Iolyx pharmaceuticals, Complement Therapeutics, Boehringer Ingelheim, Jansen, and Topcon. J.G.F. and E.M.M have a patent (VISTA) with a license option to Topcon Healthcare. The other authors report no disclosures.
